MSB 8.42% $1.03 mesoblast limited

Ann: Update on Novartis Agreement, page-200

  1. 3,352 Posts.
    lightbulb Created with Sketch. 276
    and yet in all this time, none of that "stunning" data for any of the indications has turned approval, or revenue.

    and interesting you mention Teva bailing - thats about 4 in 5 years who've walked away right?

    just trying to think what the common denominator might be....
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.